Buyer assessment
What this record supports
Reviewed evidence establishes Biochimpharm as a Georgian company offering products including Bacteriophage preparations. The public record ties the company to Tbilisi.
Source mix: 1 reviewed source is outside the company’s own web domain. This adds corroboration, but it does not make every operating claim independently verified.
This profile supports initial discovery and diligence planning. It is not evidence that the company has available capacity, meets a buyer’s compliance standard or has been commercially approved.
Product scope
What the company makes
Facility geography
Known locations and operating sites
Public company address; facility investment independently corroborated
Public company address
Company address · Tbilisi
Operating evidence
Documented capabilities and claims
Capabilities
Research, development, commercialization and manufacture of bacteriophage products
Company StatedFacilities
Modernized manufacturing facility opened in 2022 following a EUR 6 million project
Institutionally CorroboratedCertifications
Facility described as converted and equipped in line with EU GMP guidelines
Not A Current CertificateQualification gaps
Questions to ask next
These are the highest-priority questions raised by the missing public evidence.
- Obtain the current registry extract and confirm the contracting legal entity and registration number.
- Obtain current certificate or audit documents and verify the legal entity, facility, scope, issuer and expiry date.
- Request current line-level capacity, utilization and actual output for the relevant product.
- Request recent export markets and shipment evidence for the products under consideration.
- Confirm whether private-label or contract work is accepted, including development terms and ownership of tooling or artwork.
See every unverified field
- Company Registration Number
- Current GMP Certificate
- Certificate Scope And Expiry
- Capacity
- Export Markets
- Contract Manufacturing
- MOQ
- Lead Time
- Employee Count
Evidence log
Sources
- Biochimpharm aboutTier 1 · Accessed Sep 17, 2026
- Biochimpharm contactTier 1 · Accessed Sep 17, 2026
- EU Delegation to Georgia facility announcementTier 1 · Accessed Sep 17, 2026